宫颈液基细胞学检测筛查宫颈病变2445例分析  

The Analysis of 2445 Cases of Cervical Lesions with Cervical TCT Screening

作　　者：虞丰[1] 阮玉兰[1] 周晔[1] 仇志琴[1] 

机构地区：[1]南京医科大学附属无锡第二人民医院妇科,江苏无锡214002

出　　处：《现代生物医学进展》2009年第20期3918-3920,共3页Progress in Modern Biomedicine

摘　　要：目的:采用液基细胞学检测(TCT)方法,探讨其在妇科宫颈病变细胞学筛查中的临床应用价值。方法:选择我院2007年1月-2008年12月接受宫颈病变筛查的患者2445例,收集宫颈脱落细胞,采用TCT技术检测,细胞学分类采用TBS分类标准诊断,对细胞学检查阳性者行阴道镜指引下多点活检,将细胞学检查结果与活检结果作对比分析。结果:2445例受检者中细胞学阳性病例196例,阳性检出率8.02%。其中非典型鳞状细胞(ASCUS)占5.8%;低度鳞状上皮内病变(LSIL)占1.5%;高度鳞状上皮内病变(HSIL)占0.6%;鳞癌(SCC)占0.1%。阳性病例阴道镜下活检结果与细胞学检查结果符合。结论:TCT检查能准确反映宫颈病变情况,在妇科宫颈病变筛查中有较高的临床应用价值,可作为临床宫颈癌普查方法。Objective： The method of liquid-based cytology test （TCT） was used to investigate the clinical application value in cervical lesions with gynecologic cytology screening. Method： Select 2445 patients who accept screening for cervical lesions in our hospital fi＇om January 2007 to December 2008, collect cervical exfoliated cells, adopt TCT detection and TBS Detection of diagnostic classification criteria. The cytology-positive patients take colposcopy biopsy under the guidance of multi-point, and then doing comparative analysis with cytology results and biopsy results. Results： The positive detection rate was 8.02% in 196 cytology-positivecases of 2445 patients. Percent of ASCUS was 5.8%, and LSIL 1.5%, HSIL 0.6%, SCC 0.1%. The results of cytology was coincide with biopsy. Conclusion： TCT checking can exactly reflect cervical lesions. It can be used to check Cervical cancer with its high clinical application value in screening gynecological cervical lesions.

关 键 词：液基薄层细胞学技术 TBS分类标准 宫颈病变 

分 类 号：R711.74[医药卫生—妇产科学]